ARKG

Fund Description
The Fund is concentrated in any industry or group of industries in the health care sector, including, in particular, issuers having their principal business activities in the biotechnology industry. Other industries in the health care sector include medical laboratories and research, drug manufacturers and agricultural chemicals.
Fund Profile
Fund Name ARK Genomic Revolution Multi-Sector ETF
Fund Exchange Ticker ARKG
Fund Sponsor ARK Funds
Fund ISIN US00214Q3020
Net Expense Ratio 0.75 %
Fund Inception Date 31 October 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Active
Index Name Not Applicable
Index Provider Not Applicable
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Funds Combining Developed & Emerging Exposure
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 22 March 2019
Asset Under Management 380.47 Million (USD)
1 Month Total Return 10.35 %
Year To Date Return 33.40 %
1 Year Total Return 16.17 %
3 Year Annualized Total Return 24.37 %
NAV 31.9587
Share Outstanding 11,905,000
Top 10 Holdings (25 March 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
INVITAE CORP NVTA EQUI 0.1168
ILLUMINA INC ILMN EQUI 0.0890
INTELLIA THERAPEUTICS INC NTLA EQUI 0.0719
EDITAS MEDICINE INC EDIT EQUI 0.0620
VERACYTE INC VCYT EQUI 0.0611
MEDIDATA SOLUTIONS INC MDSO EQUI 0.0501
NANOSTRING TECHNOLOGIES INC NSTG EQUI 0.0438
CRISPR THERAPEUTICS AG CRSP EQUI 0.0433
BLUEBIRD BIO INC BLUE EQUI 0.0384
CELLECTIS - ADR CLLS EQUI 0.0347